Evidence map›Paper›PMID 25511080›Full record

ArticleJournal of bone and mineral metabolism2016

The functional mechanism of simvastatin in experimental osteoporosis.

Lifen Dai, Ming Xu, Haiying Wu, Lanjie Xue, Dekai Yuan, Yuan Wang, Zhiqiang Shen, Hongbin Zhao, Min Hu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of bone and mineral metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Lifen DaiKunming Research Center for Molecular Medicine, Kunming University, Kunming, 650214, People's Republic of China.
Ming XuKunming Research Center for Molecular Medicine, Kunming University, Kunming, 650214, People's Republic of China.
Haiying WuDepartment of Emergency Medicine and Intensive Care Unit, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, People's Republic of China.
Lanjie XueFaculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, 650500, People's Republic of China.
Dekai YuanKunming Research Center for Molecular Medicine, Kunming University, Kunming, 650214, People's Republic of China.
Yuan WangKunming Research Center for Molecular Medicine, Kunming University, Kunming, 650214, People's Republic of China.
Zhiqiang ShenSchool of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, 650500, People's Republic of China.
Hongbin ZhaoDepartment of Emergency Medicine and Intensive Care Unit, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, People's Republic of China. 596829191@qq.com.
Min HuKunming Research Center for Molecular Medicine, Kunming University, Kunming, 650214, People's Republic of China. humin999@aliyun.com.
Kunming Medical University · CNKunming University · CNKunming University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis is a systemic and metabolic bone disease. New drugs with good curative effect, fewer side effects, and high safety need to be developed urgently. Recently, simvastatin has been used to treat osteoporosis more frequently; however, its clinical effect and treatment mechanism are still unknown. With the use of animal models, the treatment effectiveness of simvastatin on experimental osteoporosis was investigated and the functional mechanism was preliminarily explored. The results show that simvastatin significantly increased the mechanical parameters such as maximum load, stiffness, and energy-absorbing capacity, and improved the microarchitecture. They indicated that the antiosteoporosis activity of simvastatin may be due to the promotion of proliferation and differentiation of osteoblasts. Simvastatin was effective in treating experimental osteoporosis. This study provides necessary experimental evidence for the clinical application of simvastatin in osteoporosis treatment.

Indexed as

AnimalsBone DensityCell DifferentiationCell ProliferationDisease Models, AnimalOsteoblastsOsteoporosisSimvastatinSimvastatinAnimal modelBone mineral densityOsteoblastOsteoporosisSimvastatin

Identifiers

PMID25511080
OpenAlexW2158921672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.